Enforcement BriefingBack to stories →
← Back to stories
Billing fraud & false claimsNew in this edition

Jacksonville pharmacy owner and accountant indicted over alleged $51 million human immunodeficiency virus (HIV) medication kickback scheme

The U.S. Attorney for the Middle District of Florida announced on November 12 a 31-count indictment charging Charlie Bernard Griffin III with health care fraud and money laundering and Ethelbert Chinenye Nwanegbo, an accountant, with money laundering. According to the indictment, Griffin's First Coast Community Development pharmacy agreed to pay a marketing company $200 per referral for human immunodeficiency virus (HIV) post-exposure prophylaxis medications, payable only if the claim was paid, and used false diagnosis codes showing the patients had, or had been exposed to, HIV or a sexually transmitted disease on prescriptions authorized by a nurse practitioner who never saw the patients. The indictment alleges reimbursements of about $51 million from Medicare, Medicaid and private insurers. These are charges, not findings of guilt.

Background

According to the indictment, the marketing company's representatives collected insurance information while signing people up for free government-sponsored cellphones. Three others, the marketing company's owner, the pharmacist and the nurse practitioner, were charged separately and each agreed to plead guilty.

Who this affects

Hospital outpatient and specialty pharmacies, and prescribers who sign prescriptions generated by third parties.

Why it matters

Inference: the release states that a marketer's being paid per referral based on whether a claim is paid is an illegal kickback. A pharmacy or 340B contract-pharmacy marketing arrangement that pays per referral or per prescription would need its own assessment against that statement; the release does not say such arrangements carry the same exposure.

Scope and timing

Authority status
Allegation
Responsible owner
Pharmacy; Compliance; Legal
Publication date
2026-11-12
Other dates
Indictment announced November 12, 2026; the indictment's return date is not stated in the release.

Not established

The indictment itself was not retrieved, and its return date is not in the release.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Enforcement Briefing report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies